Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index down 1.21% in March (-0.23% YTD); two-thirds of CTAs report losses

Tuesday, April 17, 2012
Opalesque Industry Update: Managed futures lost 1.21% in March according to the Barclay CTA Index compiled by BarclayHedge. The Index is down 0.23% after the first three months of 2012.

“Losses for March were widespread, as 66 percent of reporting managers ended the month in the loss column,” says Sol Waksman, founder and president of BarclayHedge.

“The river of red was wide, but fortunately it wasn’t deep.”

Six of Barclay’s eight CTA indices lost ground in March. The Barclay Diversified Traders Index dropped 1.85%, Systematic Traders were down 1.59%, Financial & Metals Traders lost 1.05%, and Currency Traders slipped 0.38%.

“US equity markets moved higher for another month, but gains from long positions in this sector were not enough to overcome losses in the other sectors,” says Waksman.

“Commodity prices moved lower on concerns of slowing in China, which in turn negatively impacted currencies of countries that are large exporters of commodities. Prices for US Treasuries also dropped in March.”

On the positive side of the ledger, the Barclay Agricultural Traders Index gained 1.80% in March, and Discretionary Traders added 0.39%.

“Discretionary traders are not as dependent on momentum driven trends as most other CTAs, and were able to eke out a profit in a difficult month,” says Waksman.

The Barclay BTOP50 Index, which measures performance of the largest CTAs, dropped 1.66% in March, cancelling out gains of 0.61% and 0.60% in the first two months of 2012. At the end of the first quarter, the BTOP50 is down 0.46%.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its